The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Amgen Australia Pty Ltd
Regulatory activities for this sponsor.
Loading...
Sponsor content
167 result(s) found, displaying 1 to 10
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TEPEZZA teprotumumab 500 mg injection powder vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for UPLIZNA inebilizumab 100 mg/10 mL concentrated injection vial.
-
Prescription medicine registrationActive ingredients: teprotumumab.
-
Prescription medicine registrationActive ingredients: inebilizumab.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for XGEVA denosumab (rch) 120 mg/mL solution for injection pre-filled syringe with automatic needle guard.
-
Prescription medicine registrationActive ingredients: blinatumomab.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for REXADEV denosumab (rch) 60mg/1mL solution for injection prefilled syringe with automatic needle guard.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CORORA denosumab (rch) 60mg/1mL solution for injection prefilled syringe with automatic needle guard.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ZEROUNT denosumab (rch) 70mg/mL (120mg/1.7mL) solution for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for DEPTARGIS denosumab (rch) 60mg/1mL solution for injection prefilled syringe with automatic needle guard.